The global anti-anxiety drug market is witnessing robust growth due to rising prevalence of anxiety disorders, stress-related conditions, and mental health awareness. The market includes benzodiazepines, SSRIs, SNRIs, and novel anxiolytic agents. Increasing healthcare access, telemedicine adoption, and improved diagnosis rates are driving demand. https://www.databridgemarketresearch.com/reports/global-anti-anxiety-drug-market